Evidence map›Paper›PMID 30944174›Full record

ArticleThe Journal of biological chemistry2019

Dynamic and structural differences between heme oxygenase-1 and -2 are due to differences in their C-terminal regions.

Brent A Kochert, Angela S Fleischhacker, Thomas E Wales, Donald F Becker, John R Engen, Stephen W Ragsdale

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Regulation of protein function and degradation by heme, heme responsive motifs, and CO.Critical reviews in biochemistry and molecular biology · 2022
    Review
  11. Observational
  12. Immune Modulation by Inhibitors of the HO System.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Brent A KochertDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115.
Angela S FleischhackerDepartment of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109.
Thomas E WalesDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115.
Donald F BeckerDepartment of Biochemistry, Redox Biology Center, University of Nebraska, Lincoln, Nebraska 68588.
John R EngenDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115.
Stephen W RagsdaleDepartment of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109. Electronic address: sragsdal@umich.edu.
Northeastern University · USUniversity of Michigan · USUniversity of Nebraska–Lincoln · US

Funding

Redox Biology CenterP30GM103335 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI BECKER, DONALD F · 2012 to 2016
$4.3M
Spectroelectrochemistry of the Novel PutA FlavoproteinR01GM061068 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI BECKER, DONALD F · 2001 to 2015
$3.7M
Redox Regulation of Heme Oxygenase-2 and the Nuclear Receptor Rev-Erb-beta by their Heme Responsive MotifsR01GM123513 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAGSDALE, STEPHEN WILEY · 2017 to 2020
$1.5M
NIGMS NIH HHS P30 GM103335NIGMS NIH HHS R01 GM061068NIGMS NIH HHS R01 GM123513
6 · The paper itself

Abstract

Heme oxygenase (HO) catalyzes heme degradation, a process crucial for regulating cellular levels of this vital, but cytotoxic, cofactor. Two HO isoforms, HO1 and HO2, exhibit similar catalytic mechanisms and efficiencies. They also share catalytic core structures, including the heme-binding site. Outside their catalytic cores are two regions unique to HO2: a 20-amino acid-long N-terminal extension and a C-terminal domain containing two heme regulatory motifs (HRMs) that bind heme independently of the core. Both HO isoforms contain a C-terminal hydrophobic membrane anchor; however, their sequences diverge. Here, using hydrogen-deuterium exchange MS, size-exclusion chromatography, and sedimentation velocity, we investigated how these divergent regions impact the dynamics and structure of the apo and heme-bound forms of HO1 and HO2. Our results reveal that heme binding to the catalytic cores of HO1 and HO2 causes similar dynamic and structural changes in regions (proximal, distal, and A6 helices) within and linked to the heme pocket. We observed that full-length HO2 is more dynamic than truncated forms lacking the membrane-anchoring region, despite sharing the same steady-state activity and heme-binding properties. In contrast, the membrane anchor of HO1 did not influence its dynamics. Furthermore, although residues within the HRM domain facilitated HO2 dimerization, neither the HRM region nor the N-terminal extension appeared to affect HO2 dynamics. In summary, our results highlight significant dynamic and structural differences between HO2 and HO1 and indicate that their dissimilar C-terminal regions play a major role in controlling the structural dynamics of these two proteins.

Indexed as

Molecular Dynamics SimulationProtein MultimerizationAmino Acid MotifsDeuterium Exchange MeasurementHemeHeme Oxygenase-1Heme Oxygenase (Decyclizing)HumansProtein DomainsHemeHeme Oxygenase-1heme oxygenase-2Heme Oxygenase (Decyclizing)HMOX1 protein, humanconformational changeenzyme catalysisenzyme kineticsenzyme mechanismheme homeostasisheme oxygenasehydrogen exchange mass spectrometrymembrane anchormembrane proteinprotein dynamics

Identifiers

PMID30944174
PMCPMC6527177
OpenAlexW2932530892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.